Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1643 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Shprintzen-Goldberg Craniosynostosis Syndrome | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| SGS | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Shprintzen-Goldberg craniosynostosis syndrome (SGS; MIM 182212) is an autosomal dominant disorder caused by mutations in the SKI gene. SGS displays considerable phenotypic overlap with Marfan syndrome (MFS; MIM 154700) and Loeys-Dietz syndrome (LDS; MIM 609192, 610168, 613795 & 614816) with the additional findings of intellectual disability, infantile muscular hypotonia, and craniosynostosis. The typical craniofacial features are: craniosynostosis, dolichocephaly, hypertelorism, down-slanting palpebral fissures, proptosis, malar hypoplasia, a high narrow palate, micrognathia and low set ears. The reported skeletal features are: arachnodactyly, pectus deformity, camptodactyly, joint hypermobilty / contractures and scoliosis. Cardiovascular findings may include: mitral valve prolapse and aortic root dilation. Other findings include: inguinal and umbilical hernia, minimal subcutaneous fat and hyperelastic skin. SKI is a proto-oncogene that represses transforming growth factor beta activity (TGF-%u03B2). Mutations in SKI are thought to lead to a loss of the suppression of the TGF-%u03B2 signaling cascades. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| SKI | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 182212 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Craniosynostosis and Craniofacial Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.